Treatment of Subacromial Shoulder Pain by Individual or Group Physiotherapy Following Corticosteroid Injection

• Status: Completed
• Trial end date: 2013-02-10
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is therefore to examine the clinical effectiveness and provide an economic analysis of individual versus group physiotherapy, following corticosteroid injection, for management of Subacromial Impingement (SAI) of the shoulder.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: South Eastern Health and Social Care Trust
• Collaborators: Northern Ireland Clinical Trials Unit; Queen's University, Belfast; University of Ulster
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• unilateral shoulder pain of more than 4 weeks duration and a Shoulder Pain and Disability Index (SPADI) score of >= 30 as this represents significant disability. Shoulder pain is defined as pain in the shoulder region, including the upper arm, elicited by active or passive shoulder movement. The diagnosis of "subacromial pain" is defined by range as no limitation in passive range of movement or restriction of passive range of movement mainly in abduction rather than external rotation.

Exclusion Criteria:

• inability to give informed consent

• physiotherapy or injection treatment for current shoulder pain in previous 3 months

• blood coagulation disorders

• bilateral shoulder pain

• evidence of systemic infection

• abnormal shoulder X-ray defined as significant glenohumeral or subacromial joint space narrowing suggesting osteoarthritis of glenohumeral joint or complete rotator cuff rupture,

• evidence of rotator cuff tear, tested by external rotation lag sign, drop sign, internal rotation lag sign and static muscle resistance in external rotation, internal rotation and abduction,

• history of significant trauma to the shoulder,

• inflammatory joint disease,

• history of cerebrovascular accident,

• allergy or contraindication to Triamcinolone/contraindication to injection.

• evidence of referred pain from cervical spine disease.

• pregnancy or breast feeding

• patients whose first language is not English